Show simple item record

dc.contributor.advisorSharmin, Sabrina
dc.contributor.authorNayon, MD.Khalid Mahmud
dc.date.accessioned2024-06-06T08:56:13Z
dc.date.available2024-06-06T08:56:13Z
dc.date.copyright©2022
dc.date.issued2022-11
dc.identifier.otherID 17346034
dc.identifier.urihttp://hdl.handle.net/10361/23213
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.en_US
dc.descriptionCataloged from the PDF version of the thesis.
dc.descriptionIncludes bibliographical references (pages 44-53).
dc.description.abstractThe ability to treat sickness is continually evolving. In this field, various approaches are being used. One of the deadliest diseases for which there are now no better treatments is cancer. There is a lot of utilization of conventional techniques such as chemotherapy, radiation, targeted therapy, and immunotherapy. However, they have detrimental side effects from which there is little chance of recovery. like cytotoxicity, specificity, drug resistance to multiple drugs, and so on. However, harsh treatment is now carried out in a laboratory setting. Such as nanotechnology. Different nanoparticles are employed in this technology to transport medications to the body's diseased areas to maximize therapeutic impact while reducing negative effects. Because of their unique benefits, Nanoparticles which are1-100 nm in size, can be utilized to treat cancer because of their better permeability, decreased toxicity, increased remarkable stability, biocompatibility, retention impact, and precision targeting. These particles make use of both the tumor's properties and its surrounding environment. These nanoparticle therapies help not just with cancer therapy but also with drug resistance to many medications. To lessen toxicity, increase permeability, lessen the effect of shielding, boost the retention effect, and other effects, numerous studies have already been conducted or are now being conducted. Many more studies are required to produce the best results. This review's objective is to inform readers about recent developments in cancer treatment using nanotechnology.en_US
dc.description.statementofresponsibilityMD.Khalid Mahmud Nayon
dc.format.extent72 pages
dc.language.isoenen_US
dc.publisherBRAC Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectNanoparticlesen_US
dc.subjectCellular targetingen_US
dc.subjectMultidrug resistanceen_US
dc.subjectCryosurgeryen_US
dc.subjectTumor microenvironmenten_US
dc.subjectBlood-brain barrieren_US
dc.subjectDrug deliveryen_US
dc.subjectProtein coronaen_US
dc.subject.lcshProteins
dc.subject.lcshCancer cells
dc.subject.lcshCarcinogenesis
dc.titleNanotechnology advancement in the field of curing canceren_US
dc.typeThesisen_US
dc.contributor.departmentSchool of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record